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The laboratory model which most closely mimicks the spectrum of human glomeru- 
lonephritis results from long-term immunization of rabbits with heterologous  serum 
proteins (1-3). The membranous and/or proliferative glomerular lesions in this model 
resemble those seen in chronic glomerulonephritis  or the renal lesions of systemic lupus 
erythematosus (SLE). In previous studies of the experimental glomerulonephritis, it 
was concluded that a critical factor determining whether or not a rabbit would develop 
chronic disease was the quantity of antibody formed (1). When the host responded with 
the production of large amounts of precipitating antibodies,  acute,  self-limited  glo- 
mertflonephrifis  was common but chronic lesions were absent. Animals making mod- 
erate  amounts  of  precipitating  antibody--amounts  sufficient  to  approximately 
neutralize the daffy antigen  dose--developed chronic disease.  In an analogy to the 
quantitative precipitin reaction, animals in this latter group were designated as being 
in a state of "equivalence." Animals in "antibody excess" and "antigen excess" were 
those making large and small (or no detectable) amounts of antibody, respectively. It 
was suggested  that animals in approximate equivalence or slight antigen excess (4) 
formed more soluble  immune complexes  than  the  other  two  groups  and  that  the 
chronic lesions were mediated by the deposition  of complexes in glomemlar capillaries. 
Immunohistologic studies supported such a role for complexes  (1, 2). 
In the present study, there is confirmation of the presence of immune com- 
plexes in sera of animals with glomerulonephritis. These animals were found to 
have moderate to large amounts of nonprecipitating  antibodies.  The nonpre- 
eipitating  antibodies  formed  complexes with  the  antigen  employed  (bovine 
serum albumin) which were removed slowly from the circulation, in contrast to 
almost immediately eliminated  complexes formed in  animals  which  did  not 
develop nephritis. It is suggested that the lesser avidity of the smaller complexes 
formed by nonprecipitafing antibodies for the reticuloendothelial system is the 
main factor determining  their slower clearance and their nephrotoxicity. From 
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these observations,  it is concluded  that  the quality,  as well as  the quantity,  of 
antibody determines whether or not chronic nephritis develops. 
Materials and Methods 
Mixed breed white rabbits weighing 4-5 lb. were injected 7 days/wk  intravenously with 
crystalline bovine serum albumin (BSA), obtained from Pentex, Inc., Kankakee, Ill.  (Since 
there was initial interest in studying anti-'y-globulin factors that developed, the early phases 
of immunization used BSA additionally purified by zone electrophoresis (Pevikon, barbital 
buffer, pH 8.6 (5) to remove trace globulin components.) Later immunization utilized whole 
crystalline BSA. The dally dose of BSA was 10 mg for several weeks. The doses were increased 
subsequently to levels as high as 50 rag/day. A few of the animals were subjected to acute 
experiments (superimposed on chronic immunization) in which as much as 25 nag were given 
every 2 hr for 24 hr. 
Sera were separated from clotted blood obtained by ear artery or cardiac puncture and 
stored at  --60°C  in a  mechanical freezer. All serological procedures utilized sera obtained 
24 hr after administration of  BSA unless otherwise stated. 
Serum complement (CO lords were determined on samples stored less than 1 wk at --60°C 
using the method of Kent et at. (6). Normal rabbit sera contained 60-100 50% units (C'5~,). 
BSA-tanned  cell hemaggtutination tests were performed on sera which had been heat-inac- 
tivated (56°C for 30 min) and absorbed with washed packed sheep erythrocytes. 2% tanned 
cells were incubated with an equal volume of 0.01% BSA in pH 7.4 phosphate-buffered saline 
(PBS)  for 45 rain, washed three times with PBS, and suspended as a  0.25% suspension in 
PBS. 0.5 ml of the BSA-coated cells were added  to 0.5-ml volumes of serially diluted test 
sera and agglutination read by settling patterns after overnight refrigeration. 
Quantitative precipitin studies were performed in 8-ml calibrated conical centrifuge tubes. 
Precipitates were washed three times at O-5°C.  Protein estimations were made by the Folin- 
Ciocalteu technique using standards of rabbit "y-globulin  (7). In some studies, serum C' was 
absorbed by adding  1.0 mg of washed preformed immune precipitate  (egg albumin-rabbit 
anti-egg albumin) per milliliter of serum.  (In studies to be described,  C" removal did not 
influence the results.) 
Rabbit T-globulin concentrations of sera were estimated by a ring diffusion technique employ- 
ing agar which contained specific duck anti-rabbit "y-globulin. The ring diameters of standards 
of known concentrations of rabbit Cohn fraction II in semilogarithmic plots permitted estima- 
tions of unknowns. 
Labeling of BSA  (supplied by the authors) with 13~I was performed by Mr. B. ]. Green of 
Abbott Laboratories, North Chicago,  Ill. The specific activity was 2.05 mc/g. A  Packard 
Gamma Counter served for counting. Concentrations of BSA were calculated from standard 
curves for each experiment and corrections made on all samples for nonprotein mI by counting 
supernatants after precipitation with 20% trichloracetic acid. Rabbits, that were subjected 
to in vivo studies with 131I BSA, received Lugol's solution (1:5000) in their drinking water 
for 1 wk before and throughout the experimental period. Globulin-bound 181I BSA was meas- 
ured by the method of Farr, counting the supernatants after precipitation with 50% saturated 
ammonium sulfate (8). 
Zone centrifugation studies were performed in gradients of sucrose  (40-10%) in a  SW39 
Spinco rotor. After 15-16 hr at 35,000 rpm in a  Spinco model L  centrifuge, 0.2  or 0.5 ml 
fractions were collected by drops from  the bottoms of  tubes. 
Tissues  were fixed in neutral formalin and  prepared for histological studies by routine 
methods. 
Tissues for immunofluorescent studies were frozen in airtight tubes by immersion in dry 
ice-acetone and  stored  at  --60°C.  Cryostat  sections  (5 /~)  were  stained with fluorescein- 
labeled globulins prepared from duck anti-rabbit 3t-globulin and rabbit anti-BSA antisera. "I'H.EODORE PINCUS~  ROY  HABERKERN~  CHARLES  L. CHRISTIAN  821 
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Table I  summarizes  the data obtained  with 22 rabbits  injected  daily with 
BSA. Acute proteinuria  (between 9 and  14 days)  occurred in six animals.  16 
rabbits were immunized for periods in excess of 10 wk. Three rabbits developed 
TABLE  I 
Summary  of Course of Immunization  and  Development of Proteinuria  in  gg  Rabbits 
Rabbits 
Proteinuria 
Chronic* 
16-14  1+ (18 wk) 
16-23  ~+  (18 wk) 
16-12  0 
16-13  0 
16-40  0 
16-62  0 
16-64  0 
16-80  0 
16-31  I+  (14 wk) 
16-16  0 
16-18  0 
16-19  0 
16-20  0 
16-21  0 
16-26  0 
16-32  0 
16-34  0 
16-38  0 
16-41  0 
16-61  0 
16-68  0 
16-69  0 
Comments 
Sacrificed 22 wk, soluble complexes present 
"  22  "  "  "  " 
Died  at  the end of an acute study at  14 wk in 
which 300  mg BSA was  administered  over  a 
24  hr  period.  Histologic  picture  of  acute 
glomerulonephritis 
Sacrificed 22 wk 
~4  9  ~C 
"  11  " 
"  11  " 
"  11  ".  No  chronic  proteinuria  but 
small  amount  circulating  soluble  complexes 
Sacrificed  18  wk,  soluble  complexes  present 
Died at end of acute experiment at 8 wk 
,,  ,,  ,4  ,,  ,,  ,,  4,  10  " 
"  during  renal  biopsy  at  2  wk.  Histologic 
picture of acute glomerulitis 
Sacrificed 27 wk 
4~  5  ~t 
Study terminated at 27 wk 
"  "  "  20  " 
"  "  "  20  " 
"  "  "  20  " 
Died at 2 wk--acute glomemlonephritis 
Study terminated at 11 wk 
Sacrificed 11 wk 
Study terminated at 11 wk 
* Figures in parentheses indicate the onset of chronic proteinuria. The three rabbits with 
chronic proteinuria manifested persistent proteinuria until the time of sacrifice. 
~/Seven animals were subjected to acute experiments (1-2 days) after 8-14 wk of immuni- 
zation, during which time larger doses of antigen were administered. The initial dose for a/l 
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chronic proteinuria;  these rabbits  were investigated in  the  studies  to be  re- 
ported below, along with the other immune animals and nonimmune animals. 
Clearance of Antigen in Immune Animals with and without Proteinuria.--Ini- 
tial studies were done to determine clearance rates of BSA, over a 24 hr period, 
in animals receiving daily immunization. Text-fig. 1 illustrates such a study in 
nine immune rabbits and one control rabbit. Each animal was injected with 30 
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TExT-FIG. 1. Disappearance rates of 131I-labeled BSA from  serum after injection of 30 mg 
BSA into 10 rabbits. (The control animal had not been immunized.) 
mg of BSA and bled at 15 min, 1, 2, 5, 12, and 24 hr intervals. The control ani- 
mal showed the slowest clearance rate compatible with compartment equilibra- 
tion and protein catabolism (9). Five of the animals showed very low levels of 
circulating antigen  (less than 4  ~g/ml)  15 min  after injection. Four of  nine 
immune animals had, at 15 min, circulating antigen at levels between 15 and 
280  /zg/ml.  The antigen elimination rates were  variable.  Three of  the  nine 
animals exhibited chronic proteinuria at the time of the clearance study (rabbits 
16-14, 16-23, and 16-31)--those with the greatest amount of circulating antigen. 
Table  II  summarizes  other  data  from  the  above  experiment.  Capillary 
precipitin tests (using an anti-BSA antiserum) confirmed the results illustrated TliJ~ODORE  PINCUS~  ROY  HABERKERN~  CHARLES  L.  CHRISTIAN 
m 
.~. 
.~. 
+ 
eq  ~  °°°°°°° 
~=~  =  ++ 
~°~ 
~_  ~.~  ++++ 
ig  " 
~-~= 
~o 
.~.~ 
~.~ 
~o  ~ 
~  3  NN~N~NNN 
N  N  ~ 
~N  3  ~=aa~aaa 
.o  ~  VV  VVV 
~.~  "  V"  VV  V  VV 
b  "~  V  ~  VVVVVVV 
~o  ~~~ 
.~ 
o~.=  +++ 
823 824  EXPEP~NTAL  CHRONIC  GLOMERULITIS 
in Text-fig. 1. The amounts of circulating BSA were highest in the three animals 
with chronic proteinuria using isotopic and immunological techniques. Parallel 
studies of serum complement (C')  and hemagglutinating  anfi-BSA antibody 
are also summarized in Table II. Eight of the nine immunized animals showed 
a precipitous fall in serum C', to undetectable levels, 15 min after immuniza- 
tion, with a gradual return to preimmunization levels. The C' levels were stable 
in rabbit 16-23 and the nonimmune animal. It is noteworthy that rabbit 16-23, 
which developed proteinuria, had the slowest elimination rate of antigen from 
circulation, a rate over 12 hr that was almost as slow as the control (Text-fig. 1). 
Anti-BSA antibodies (hemagglutination) were detectable in all rabbits at all 
intervals, although a fall in titer occurred immediately after injection of antigen 
1,4' 
,'# 
,:,  1.2" 
1.0. 
tO 
~0.8' 
z0.6' 
w 
~  0.4 ~ 
0,2, 
Corffrol  i 
16-42 (2 doys) x," ',  [6-14 (Ihr) 
• 
//i{i  /  " 
•  "  'i 
:  /  -A,,  ,  ,  .  v\/  ! 
f,  7/ 
:  '  i"  ;  r;  ?\  .  k  I', 
fill "•'+ 
16-23 (Ihr) 
t;x 
/  ",. 
/  •  ~. 
/.  "  X~  '  X 
x  ,  /  .  ',  /'x 
K  X" 
i  i 
5  I0  15  20 
TEXT-FIG. 2. Sucrose  density gradient patterns of protein and BSA of three rabbit sera 
after injection (intravenous) of 30 mg of mI-labeled BSA. Fractions (from the  bottom) 
were 0.2 ml. 
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with a return to preimmunizafion levels over 24 hr. Thus, with the technique 
of hemagglutination,  all  animals  remained in  antibody excess following the 
intravenous administration  of BSA  (30 mg)--even though  the  animals  with 
chronic proteinuria had, concurrently, significant amounts of circulating anti- 
gen. 
Density Gradient Studies of Sera Containing  Labeled Antigen.--The  presence 
of circulating antigen in the three rabbits which developed chronic proteinuria 
and the absence in all but one of the other rabbits supports the concept that 
circulating immune complexes induce glomerular injury. It was necessary to 
determine whether the antigen in such animals was in free or complex form. 
Density  gradient  centrifugafion studies  of sera  containing labeled  BSA  are 
illustrated in Text-fig. 2. The distribution of free antigen in the gradient is in- 
dicated by the study of a control rabbit (16-42) injected 2 days previously with 
30 mg of labeled BSA. Sera obtained from two rabbits with chronic proteinuria TtL~ODORE  PINCUS~  ROY  HAB~..RK,ERN,  CHARLES  I,.  CHRISTIAN  825 
(16-14 and 16-23), 1 hr after injection with 30 mg of BSA, had virtually all of 
the radioactivity  in fractions heavier than the 7S ~-glob,  lln (the peak concen- 
tration of ~-globulin was in fraction 12). In one animal (16~23), the label  ap- 
peared maximally in an intermediate zone between 19S and 7S peaks--in a 
fraction with the lowest protein concentration. In  rabbit  16-14,  the  labeled 
antigen  was  distributed  at  the  bottom  of  the gradient (heavier  than the 
19S peak) and in the intermediate zone. These data clearly indicated that the 
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TExT-FIG. 3. Disappearance rates of 131I-labeled  BSA in mice passively immunized with 
sera of three different rabbits,  (16-14 and  16-23  with proteinuria). 
circulating antigen in animals with chronic  proteinuria existed in the form of 
complexes and that undetectable quantities of free antigen were present. 
Passive Iramunizatian  of Mice.--Were the observed  differences in antigen 
clearance rates dependent on variability of the host's clearing mechanisms,  or 
did they reflect unique qualities of the immune response  to chronic immuniza- 
tion? To answer this question, .mice were passively immunized with 0.5 ml of 
serum (intravenously)  from individual rabbffs.  1 hr later 100/~g of mI BSA 
was injected intravenously and clearance rates of labeled  antigen were deter- 
mined. Text-fig. 3 illustrates the data obtained. The clearance rates in the mice 
were quite comparable with those in the rabbits from which the sera  derived. 
Rabbit 16-23 exhibited the slowest clearance, rabbit 16-24 a more rapid clear- 826  EXPERIMENTAL CHRONIC GLOMERULITIS 
ance, and rabbit 16-40 had almost no detectable antigen 15 rain after injection 
(Text-fig. 1). These data implied that the varied clearance rates in chronically 
immunized rabbits reflected properties intrinsic to the immune response, rather 
than differences in clearing mechanisms. 
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In Vitro Studies of Immune Complex Forma2io~.--Sera  of individual rabbits 
were studied with the Farr technique, using varying quantities of mI BSA. The 
distribution of antigen in immune precipitate, in soluble complex (precipitated 
by 50% saturated  (NH4)2S04),  and in free  form  (soluble in 50%  saturated 
(NH4)~SO4), was determined. Data obtained from the study of two sera (16-31) "_t'REODORE PINCUS, ROY HABERKERN,  CHARLES L. CHRISTIAN  827 
and  16-62) is illustrated  in Text-fig.  4.  Sera from rabbit 16-31, which exhib- 
ited chronic proteinuria, formed almost entirely soluble complexes.  Serum from 
rabbit  16-62 (without proteinuria)  formed  precipitating immune  complexes. 
Over a wide range of antigen  concentrations,  there  were negligible quantities 
of free antigen.  The findings, when still  larger  amounts of antigen  (5-10 rag) 
were added to 1 ml  of  serum  16-62, did not resemble  the pattern observed 
with serum 16-31. Large excesses of free antigen were required to produce sig- 
nificant  quantities of soluble complex. Table III summarizes data obtained from 
the study of six rabbits using variable amounts of antigen. 
Studies of Antibodies Produced in Animals Before Nephritis A ppeared.--Did 
the animals with proteinuria, that possessed largely nonprecipitating antibody, 
TABLE III 
In Vitro Distribution of 131I-Labded BSA  (Farr Technique) in Six Rabbit Sera 
Distribution of antigen (varying amounts) added in vitro to  1 ml of  rabbit  sera 
Chro- 
Ani-  nic  mals  pro-  10O/~g  200~g  500~g  10O0 pg  2000/~g 
tein 
uria 
[6-14 
[6-23 
16-31 
L6-80 
L6-62 
L6-64 
1-b 
4+ 
3+ 
0 
0 
0 
tom o 
Ppt.  plex 
58  30 
100  9 
110  6 
110  9 
Com- 
Ppt.  ~  plex 
1"  280* 
64  150 
130  76 
190  10 
205  0 
Ppt. 
78 
11  35 
16  43 
0  457 
11  490 
Com- 
plex 
444 
507 
438 
2 
8 
Free  Ppt. 
6 
12  33 
18  53 
12  963 
4  987 
Com- 
plex 
833 
629 
72 
23 
Free  Ppt. 
155  11 
408  52 
12  637 
II  765 
Com- 
plex 
1280 
950 
1050 
1015 
82~ 
113( 
47( 
26( 
Ppt., precipitate. 
* 250 pg BSA added. 
develop this type of antibody late in the course of their chronic immunization, 
or did they manifest this type of immune response from the beginning?  Data 
relevant to these questions is presented in Table IV. Early in  the  course of 
immunization  and before the onset of proteinuria,  the bulk of antibody pro- 
duced by these three rabbits lacked precipitating properties. 
Pathological  Findings.--All  rabbits  immunized  chronically  with  BSA had 
mild  proliferative glomerulitis.  Animals  manifesting  chronic  proteinuria  ex- 
hibited more severe lesions. The histopathological features were varied, as Fig. 
1 illustrates.  Of the three animals with chronic  proteinuria, rabbit 16-23 which 
formed immune complex  with a  sedimentation constant of approximately 10 
and which did not experience a significant drop in serum C' (see~  Text-fig. 2 and 
Table II), had the mildest lesions. The glomerular alteration was predominately 
membranous. Rabbits 16-14 and 16-31 showed more severe diffuse proliferative 
glomeruiitis;  and,  especially in  16-31, there  were necrotic loci  and  hyaline 
thrombi in  glomeruli.  Immunofluorescent studies  demonstrated  BSA in  the 828  EXPERIMENTAL CHRONIC GLOMERULITIS 
glomeruli  of animals  with  chronic  proteinuria  (Fig.  1).  The  distribution  of 
BSA  was  "lumpy."  Fluorescein-labeled  duck  anti-rabbit  v-globulin  which 
stained glomeruti faintly in rabbits 16-14 and 16-23, showed bright fluorescence 
with rabbit 16-31. Immunofluorescent studies of kidney sections from rabbits 
without proteinuria  were negative. Tissues other than  kidney were not sub- 
jected to immunofluorescent studies. 
TABLE IV 
Distribution of ml-I.~bded BSA  (Farr Technique) o2 Three Different. Intervals after lnit.io2ion 
of Immunizo2ion of Two Rabbit.s 
Rabbit 
16-14 
16-14 
16-14 
16-23 
16-23 
16-23 
Duration of 
immunization 
52 days 
150  " 
177  " 
52 days 
150  " 
177  " 
Protein- 
uria 
0 
0 
1+ 
0 
0 
4+ 
BSA added 
to 0.5 ml 
serum 
/ag 
5OO 
5OO 
250 
125 
250 
Distribution of BSA 
Ppt. 
~g 
40 
78 
<1 
<1 
<1 
Not studied 
Complex 
pg 
450 
444 
280 
140 
280 
Free 
~g 
30 
6 
1 
<I 
<I 
Ppt., precipitate. 
DISCUSSION 
The evidence presented is entirely consistent with the thesis that circulating 
immune complexes mediate the chronic  glomerulitis  resulting from daily ad- 
ministration of a heterologous serum protein. The data suggest that the quality 
of the immune response may be as important as the quantity of antibody pro- 
duced in determining whether or not an individual rabbit will develop chronic 
glomerulitis.  Clearly,  animals  that  responded  with  the  production  of  large 
amounts  of antibody  (as  determined  by precipitin  studies)  did  not  develop 
chronic proteinuria. This confirmed previously reported data (1-3). However, 
in the present  studies,  animals developing chronic glomerulifis exhibited  ap- 
preciable  quantities  of  antibody  which  was  not  demonstrable  by  precipitin 
analysis but which  was detected  by hemagglutination  and the Farr  globulin 
precipitation  technique.  It appeared  that  this  type of immune response,  i.e. 
production of nonprecipitating antibody,  correlated closely with the develop- 
ment of chronic glomerulitis and that the slower reticuloendothelial clearance 
of complexes formed with such antibodies would favor glomerular deposition. 
The passive immunization studies in mice, followed by observations of the 
clearance  of labeled  antigen,  offered evidence that  the  phenomena observed 
were dependent on intrinsic properties of the antibodies; and this was confirmed, 
in vitro, in studies using the Farr technique. "£ti~:ODORE PINCUS, ROY HABERKERN, CHARLES L. CHRISTIAN  829 
Data, which are summarized in Table III, indicate that the development of 
nonprecipitating antibody was not a late development in the course of chronic 
immunization--rather, it was evident in the early immune response. The detec- 
tion of this type of response early may have predictive value in determining 
which animals will develop chronic disease. (Such studies are in progress.) In 
previous studies, and in the present one, a  minority of animals subjected to 
chronic immunization have developed chronic glomerular lesions--usuaUy 10- 
20%. 
Why did a minority of animals respond to chronic immunization by the pro- 
duction of predominately nonprecipitating antibody? There are two main pos- 
sibilities:  (a)  a  qualitatively unique  antibody is  formed which,  because  of 
intrinsic properties  or lesser avidity for antigen, is unable to form insoluble 
immune aggregates, or (b) the immune response, in such animals, is directed at 
a limited number of antigenic determinates on the complex protein antigen--a 
number too small to permit lattice formation and precipitation of the immune 
reactants. The evidence, which so far favors the latter explanation, will be re- 
ported separately.  1 
If the above thesis is correct,  i.e.  that the production of nonprecipitating 
antibody favors the development of chronic serum sickness, it must be admitted 
that other factors are likely important. One is the duration of exposure to cir- 
culating soluble complexes. The two animals studied in detail possessed largely 
nonprecipitating antibodies for weeks before chronic proteinuria was observed. 
Another factor may relate to the varied degree of complexity of soluble com- 
plexes formed.  There  is  abundant  evidence relating biological properties  of 
immune complexes to their molecular size (10-12). It was of interest that one 
animal  (16-23),  that had predominately a  low molecular weight complex in 
vivo,  exhibited minimal  inflammatory lesions--yet had  chronic  proteinuria 
with mainly membranous changes. One can calculate from the sedimentation 
property of the labeled antigen in rabbit 16-23 (Text-fig. 2) that the complex 
formed was comprised of no more than 2 moles of antibody. The sera of the 
other animals studied (16-14 and 16-31) formed, in vivo and in vitro, complexes 
with antigen that were heavier than 19S components of serum.  These more 
complex soluble immune aggregates would be expected to have greater biologi- 
cal activities; i.e. C' inactivation and the induction of inflammation. The ani- 
mals with the heavier complexes,  unlike rabbit 16-23, exhibited  an abrupt de- 
crease in C' upon administration of antigen and manifested more inflammatory 
glomerular lesions. 
Whether or not the experimental studies herein reported have relevance to 
human disease is unknown. The similarities between the model of experimental 
chronic serum sickness and SLE are numerous. It is attractive to postulate 
1 Christian, C. L., T. Pincus, and R. C. Haberkern. Manuscript in preparation. 830  EXPEP~NTAL  CHRONIC  GLOM~RULITIS 
that SLE is immune complex disease in which the antigen is not known.  ~  In the 
experimental model, if the inducing antigen were not known and available for 
isotopic labeling, the chances are remote that the offending antigen could have 
been identified from studies of serum or the intact animal. Even in the animal 
(16-23)  with the largest quantity of circulating antigen (280 #g/ml), the com- 
plexes would not have been detected without the isotopic label (Text-fig. 2). 
If the suggested basis for development of nonprecipitating antibody is correct 
(i.e. the immune response recognizes a limited number of antigenic determinates 
on a complex antigen), it may be that the patient with SLE nephritis or post- 
streptococcal glomerulonephritis responds  to  an  immunologic stimulus with 
the production of antibodies that have a limited specificity for determinates on 
a  complex environmental or autologous antigen. Theoretically, "autologous" 
antigens would be more likely inducers of this kind of immune response than 
exogenous antigens. 
SUGARY 
Three of  16 rabbits  injected  (intravenously) daily with crystalline  bovine 
serum albumin (BSA) for periods in excess of 10 wk developed chronic glomer- 
ulonephrifis. In vivo, animals with chronic proteinuria formed variable quan- 
tities of  soluble  complex  after  injection  of  antigen  while  animals  without 
proteinuria  exhibited  rapid  removal  of  the  injected  BSA.  In  vitro  studies 
demonstrated that a major part of the  antibodies produced  by rabbits with 
chronic nephritis lacked precipitating properties.  Interpretations of these ob- 
servations were presented in the discussion. 
It is suggested that, in addition to quantity, quality of antibody plays an 
important  role  in  the  development  of  chronic  serum  sickness.  Complexes 
formed with nonprecipitating antibody, which are less  rapidly removed from 
circulation, would have a greater opportunity to deposit in glomeruli and induce 
inflammation. 
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FIG. 1. Photomicrographs of hematoxylin-eosin-stained  kidney sections (upper) and 
immunofluorescent preparations (lower)  stained with fluorescein-labeled  rabbit anti- 
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(Pincus et al.: Experimental chronic glomerulitis) 